Please assess the completion status of the following clinical trial:

Trial Title: Llama Antibody, Rotavirus Diarrhoea, Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Sex: Male~* Age: 6-24 months~* History of watery diarrhoea of 48 hours or less~* At least 4 liquid stools during the previous 24 hours~* No V. cholerae in a dark-field test microscopy~* Presence of rotavirus in stool as determined by ELISA~* Written informed consent for participation by respective parents/guardians~Exclusion Criteria:~* Systemic infection(s) requiring antibiotic treatment~* Severe malnutrition (W/H \<-3SD)~* History of bloody diarrhoea~* Patient unwilling to comply with study protocol~* Currently participating or have participated in another clinical trial during the last 3 weeks prior to this study.

- Gender: MALE
- Minimum Age: 6 Months
- Maximum Age: 24 Months
- Healthy Volunteers: f

Study Arms:
- VHH (Type: ACTIVE_COMPARATOR): The active substance is VHH batch 203027.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo product

Based on this trial design, predict the completion outcome and termination type (if applicable).